epcoritamab
abbvie,genmab
['lymsm', 'lymphoma', 'epcoritamab']
#eha2022 #presidentialsymposium primary results of subcutaneous #epcoritamab dose expansion in patients with relapsed or refractory large b-cell lymphoma: a phase 2 study #lymsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @SIOGorg. Councilor @EHA_Hematology Executive Board. Chairman SWG “Aging and Hematology”